Cutaneous Leishmaniasis (CL) in Saudi Arabia: Current Status
Keywords:
Cutaneous leishmaniasis, Saudi Arabia, LeishmaniaAbstract
Cutaneous leishmaniasis (CL) is a major tropical infection of public health importance. It is caused by a group of protozoan intracellular parasites. Several factors contribute to the prevalence and transmission of CL. More than 1400 cases of CL were reported in Saudi Arabia in 2012. Although several studies have looked at CL in Saudi Arabia and emphasized on the Eastern province of the country, the highest prevalence of CL was reported in Al-Qaseem area. In this review, we report on the species of Leishmania parasites causing CL in Saudi Arabia, its distribution and its incidence in the past seven years. We also report on the methods used to diagnose this infection and the treatment protocols used to treat CL in the country.
Downloads
References
Reithinger, R., Dujardin, J.C., Louzir, H., Pirmez, C., Alexander, B. & Brooker, S. (2007). Cutaneous leishmaniasis. Lancet Infect. Dis., 7(9): 581–596. https://doi.org/10.1016/S1473-3099(07)70209-8.
Health Statistical Year Book (2012). Ministry of Health, Saudi Arabia.
World Health Organization, http://www.who.int/leishmaniasis (accessed on 12 May 2014).
Health Statistical Year Book (2011). Ministry of Health, Saudi Arabia.
Health Statistical Year Book (2010). Ministry of Health, Saudi Arabia.
Health Statistical Year Book (2009). Ministry of Health, Saudi Arabia.
Health Statistical Year Book (2008). Ministry of Health, Saudi Arabia.
Health Statistical Year Book (2007). Ministry of Health, Saudi Arabia.
Health Statistical Year Book (2006). Ministry of Health, Saudi Arabia.
Zakai, H.A., Chance, M.L. & Bates, P.A. (1998). In vitro stimulation of metacyclogenesis in Leishmania braziliensis, L. donovani, L. major and L. mexicana. Parasitology, 116: 305–309. https://doi.org/10.1017/s0031182097002382.
Zakai, H.A., Chance, M.L. & Bates, P.A. (1999). The axenic cultivation of Leishmania donovani amastigotes. Saudi Med. J., 20: 334-340.
http://parasite.org.au/para-site/text/leishmania-text.html (accessed on 12 May 2014).
El Hassan, A.M. (2013). Cutaneous leishmaniasis in Al-Ahsa Oasis in Saudi Arabia and in Sudan: A comparative study. Saudi J. Med. Med. Sci., 1(2): 64-71. http://dx.doi.org/10.4103/1658-631X.123642.
Peters, W., Elbihari, S., Liu, C., Le Blancq, S.M., Evans, D.A., Killick-Kendrick, R., Smith, V. & Baldwin, C.I. (1985). Leishmania infecting man and wild animals in Saudi Arabia. 1. General survey. Trans. R. Soc. Trop. Med. Hyg., 79(6): 831–839. https://doi.org/10.1016/0035-9203(85)90130-0.
Al-Zahrani, M.A., Peters, W., Evans, D.A., Smith, V. & Ching Chin, I. (1989). Leishmania infecting man and wild animals in Saudi Arabia. 6. Cutaneous leishmaniasis of man in the south-west. Trans. R. Soc. Trop. Med. Hyg., 83(5): 621–628. https://doi.org/10.1016/0035-9203(89)90376-3.
Elbihari, S., Cheema, A.H. & El-Hassan, A.M. (1987). Leishmania infecting man and wild animals in Saudi Arabia. 4. Canine cutaneous leishmaniasis in the Eastern Province. Trans. R. Soc. Trop. Med. Hyg., 81(6): 925–927. https://doi.org/10.1016/0035-9203(87)90353-1.
Magill, A.J., Grögl, M., Gasser, R.A., Jr, Sun, W. & Oster, C.N. (1993). Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N. Engl. J. Med., 328(19): 1383–1387. https://doi.org/10.1056/NEJM199305133281904.
Al-Tawfiq, J.A. & AbuKhamsin, A. (2004). Cutaneous leishmaniasis: a 46-year study of the epidemiology and clinical features in Saudi Arabia (1956-2002). Int. J. Infect. Dis., 8(4): 244–250. https://doi.org/10.1016/j.ijid.2003.10.006.
Al-Qurashi, A.R., Ghandour, A.M., Osman, M. & Al-Juma, M. (2000). Dissemination in cutaneous leishmaniasis due to Leishmania major in different ethnic groups in Saudi Arabia. Int. J. Dermatol., 39(11): 832–836. https://doi.org/10.1046/j.1365-4362.2000.00059.x.
Amin, T.T., Al-Mohammed, H.I., Kaliyadan, F. & Mohammed, B.S. (2013). Cutaneous leishmaniasis in Al Hassa, Saudi Arabia: epidemiological trends from 2000 to 2010. Asian Pac. J. Trop. Med., 6(8): 667–672. https://doi.org/10.1016/S1995-7645(13)60116-9.
Postigo, J.A. (2010). Leishmaniasis in the World Health Organization Eastern Mediterranean Region. Int. J. Antimicrob. Agents, 36(Suppl 1): S62–S65. https://doi.org/10.1016/j.ijantimicag.2010.06.023.
Al-Zahrani, M.A., Peters, W., Evans, D.A., Chin, C., Smith, V. & Lane, R.P. (1988). Phlebotomus sergenti, a vector of Leishmania tropica in Saudi Arabia. Trans. R. Soc. Trop. Med. Hyg., 82(3): 416. https://doi.org/10.1016/0035-9203(88)90142-3.
Goto, H. & Lindoso, J.A. (2010). Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Expert Rev. Anti Infect. Ther., 8(4): 419–433. https://doi.org/10.1586/eri.10.19.
Vega-López, F. (2003). Diagnosis of cutaneous leishmaniasis. Curr. Opin. Infect. Dis., 16(2): 97–101. https://doi.org/10.1097/00001432-200304000-00006.
Al-Hucheimi, S.N., Sultan, B.A. & Al-Dhalimi, M.A. (2009). A comparative study of the diagnosis of Old World cutaneous leishmaniasis in Iraq by polymerase chain reaction and microbiologic and histopathologic methods. Int. J. Dermatol., 48(4): 404–408. https://doi.org/10.1111/j.1365-4632.2009.03903.x.
Sotto, M.N., Yamashiro-Kanashiro, E.H., da Matta, V.L. & de Brito, T. (1989). Cutaneous leishmaniasis of the New World: diagnostic immunopathology and antigen pathways in skin and mucosa. Acta Trop., 46(2): 121–130. https://doi.org/10.1016/0001-706x(89)90006-5.
Sassi, A., Louzir, H., Ben Salah, A., Mokni, M., Ben Osman, A. & Dellagi, K. (1999). Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia. Clin. Exp. Immunol., 116(1): 127–132. https://doi.org/10.1046/j.1365-2249.1999.00844.x.
Reed, S.G. (1996). Diagnosis of leishmaniasis. Clin. Dermatol., 14(5): 471–478. https://doi.org/10.1016/0738-081x(96)00038-7.
Shaw, J.J. & Lainson, R. (1975). Leishmaniasis in Brazil: X. Some observations of intradermal reactions to different trypanosomatid antigens of patients suffering from cutaneous and mucocutaneous leishmaniasis. Trans. R. Soc. Trop. Med. Hyg., 69(3): 323–335. https://doi.org/10.1016/0035-9203(75)90127-3.
Kar, K. (1995). Serodiagnosis of leishmaniasis. Crit. Rev. Microbiol., 21(2): 123–152. https://doi.org/10.3109/10408419509113537.
Edrissian, G.H. & Darabian, P. (1979). A comparison of enzyme-linked immunosorbent assay and indirect fluorescent antibody test in the sero-diagnosis of cutaneous and visceral leishmaniasis in Iran. Trans. R. Soc. Trop. Med. Hyg., 73(3): 289–292. https://doi.org/10.1016/0035-9203(79)90084-1.
El Safi, S.H. & Evans, D.A. (1989). A comparison of the direct agglutination test and enzyme-linked immunosorbent assay in the sero-diagnosis of leishmaniasis in the Sudan. Trans. R. Soc. Trop. Med. Hyg., 83(3): 334–337. https://doi.org/10.1016/0035-9203(89)90493-8.
Zeyrek, F.Y., Korkmaz, M. & Ozbel, Y. (2007). Serodiagnosis of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica in Sanliurfa Province, Turkey, where ACL Is highly endemic. Clin. Vaccine Immunol., 14(11): 1409–1415. https://doi.org/10.1128/CVI.00133-07.
Hailu, A. (2002). The use of direct agglutination test (DAT) in serological diagnosis of Ethiopian cutaneous leishmaniasis. Diagn. Microbiol. Infect. Dis., 42(4): 251–256. https://doi.org/10.1016/s0732-8893(01)00359-5.
Spithill, T.W. & Samaras, N. (1985). The molecular karyotype of Leishmania major and mapping of alpha and beta tubulin gene families to multiple unlinked chromosomal loci. Nucleic Acids Res., 13(11): 4155–4169. https://doi.org/10.1093/nar/13.11.4155.
Scholler, J.K., Reed, S.G. & Stuart, K. (1986). Molecular karyotype of species and subspecies of Leishmania. Mol. Biochem. Parasitol., 20(3): 279–293. https://doi.org/10.1016/0166-6851(86)90108-8.
Samaras, N. & Spithill, T.W. (1987). Molecular karyotype of five species of Leishmania and analysis of gene locations and chromosomal rearrangements. Mol. Biochem. Parasitol., 25(3): 279–291. https://doi.org/10.1016/0166-6851(87)90092-2.
Barker, D.C. (1989). Molecular approaches to DNA diagnosis. Parasitology, 99 Suppl: S125–S146. https://doi.org/10.1017/s0031182000083463.
Bishop, R.P. & Akinsehinwa, F. (1989). Characterization of Leishmania donovani stocks by genomic DNA heterogeneity and molecular karyotype. Trans. R. Soc. Trop. Med. Hyg., 83(5): 629–634. https://doi.org/10.1016/0035-9203(89)90377-5.
Yehia, L., Adib-Houreih, M., Raslan, W.F., Kibbi, A.G., Loya, A., Firooz, A., Satti, M., El-Sabban, M. & Khalifeh, I. (2012). Molecular diagnosis of cutaneous leishmaniasis and species identification: analysis of 122 biopsies with varied parasite index. J. Cutan. Pathol., 39(3): 347–355. https://doi.org/10.1111/j.1600-0560.2011.01861.x.
El-Beshbishy, H.A., Al-Ali, K.H. & El-Badry, A.A. (2013). Molecular characterization of cutaneous leishmaniasis in Al-Madinah Al-Munawarah province, western Saudi Arabia. Int. J. Infect. Dis., 17(5): e334–e338. https://doi.org/10.1016/j.ijid.2012.11.015.
Alkhawajah, A. (1998). Recent trends in the treatment of cutaneous leishmaniasis. Ann. Saudi Med., 18(5): 412–416. https://doi.org/10.5144/0256-4947.1998.412.
Zakai, H.A. & Zimmo, S.K. (2002). Effect of Itraconazole and Terbinafine on Leishmania Major Promastigotes. JKAU Med. Sci., 10: 73–80. https://doi.org/10.4197/med.10-1.9.
Zakai, H.A. & Zimmo, S.K. (2000). Effects of itraconazole and terbinafine on Leishmania major lesions in BALB/c mice. Ann. Trop. Med. Parasitol., 94(8): 787–791. https://doi.org/10.1080/00034980020027979.
Alrajhi, A.A., Ibrahim, E.A., De Vol, E.B., Khairat, M., Faris, R.M. & Maguire, J.H. (2002). Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N. Engl. J. Med., 346(12): 891–895. https://doi.org/10.1056/NEJMoa011882.
de Macedo-Silva, S.T., Urbina, J.A., de Souza, W. & Rodrigues, J.C. (2013). In vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis. PloS one, 8(12): e83247. https://doi.org/10.1371/journal.pone.0083247.
Jaffar, H. (2006). Rifampicin in cutaneous leishmaniasis – a therapeutic trial in Saudi Arabia. J. Pak. Assoc. Dermatol., 16(1): 4–9.
Zakai, H.A., Zimmo, S. & Fouad, M.A. (2003). Effect of itraconazole and terbinafine on Leishmania promastigotes. J. Egypt. Soc. Parasitol., 33(1): 97–107.
Al-Jaser, M.H. (2005). Treatment trends of cutaneous leishmaniasis in Saudi Arabia. Saudi Med. J., 26(8): 1220–1224.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2014 The author(s) retains the copyright of this article.
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
